KPWS
VKTX icon

Kestra Private Wealth Services’s Viking Therapeutics VKTX Stock Holding History

Kestra Private Wealth Services’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$510K Buy
13,064
+1,873
+17% +$60.5K 0.01% 1225
2026
Q1 		$364K Buy
11,191
+1,212
+12% +$39K ﹤0.01% 1360
2025
Q4 		$351K Buy
9,979
+312
+3% +$11.1K ﹤0.01% 1349
2025
Q3 		$254K Sell
9,667
-179
-2% -$5.34K ﹤0.01% 1450
2025
Q2 		$261K Buy
9,846
+1,018
+12% +$26.8K ﹤0.01% 1365
2025
Q1 		$213K Buy
8,828
+1,176
+15% +$37.2K ﹤0.01% 1362
2024
Q4 		$308K Buy
+7,652
New +$436K 0.01% 1124

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Kestra Private Wealth Services's VKTX Position: Q2 2026 in Review

Kestra Private Wealth Services increased its Viking Therapeutics (VKTX) stake by 17% in Q2 2026, buying an estimated $60.5K and bringing the position to 13,064 shares worth $510K. The position accounts for 0.01% of the portfolio, ranked #1225.

Kestra Private Wealth Services first reported a position in VKTX in Q4 2024 and has held it in 7 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Kestra Private Wealth Services held 13,064 shares of Viking Therapeutics worth $510K as of Q2 2026.
  • Kestra Private Wealth Services bought 1,873 Viking Therapeutics shares in Q2 2026, an estimated $60.5K.
  • Viking Therapeutics made up 0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1225 holding.
  • Kestra Private Wealth Services first reported a position in Viking Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.